GC
EXAS

Grimes & Company’s Exact Sciences EXAS Stock Holding History

Grimes & Company’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,997
Closed -$248K – 307
2021
Q2 		$248K Hold
1,997
– – 0.01% 261
2021
Q1 		$263K Buy
1,997
+297
+17% +$40.7K 0.01% 238
2020
Q4 		$225K Buy
+1,700
New +$206K 0.01% 244
2019
Q3 		– Sell
-1,700
Closed -$201K – 257
2019
Q2 		$201K Buy
+1,700
New +$171K 0.02% 236

Other funds holding EXAS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Grimes & Company's EXAS Position: Q3 2021 in Review

Grimes & Company sold out of Exact Sciences (EXAS) in Q3 2021, closing a stake of 1,997 shares — an estimated $248K sold.

Grimes & Company first reported a position in EXAS in Q2 2019 and held it in 4 quarters. The position peaked at $263K in Q1 2021. 602 funds tracked by Wall St. Rank hold EXAS as of Q3 2021.

  • Grimes & Company reported no remaining Exact Sciences position as of Q3 2021 after selling out during the quarter.
  • Grimes & Company sold 1,997 Exact Sciences shares in Q3 2021, an estimated $248K.
  • Grimes & Company first reported a position in Exact Sciences in Q2 2019 and held it in 4 quarters.
  • Grimes & Company's Exact Sciences position peaked at $263K in Q1 2021.
  • 602 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2021.

Based on Grimes & Company's 13F filing for Q3 2021, filed 8 Nov 2021.